<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">RNA Biol</journal-id><journal-id journal-id-type="iso-abbrev">RNA Biol</journal-id><journal-title-group><journal-title>RNA Biology</journal-title></journal-title-group><issn pub-type="ppub">1547-6286</issn><issn pub-type="epub">1555-8584</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38112323</article-id><article-id pub-id-type="pmc">PMC10732628</article-id>
<article-id pub-id-type="doi">10.1080/15476286.2023.2294222</article-id><article-id pub-id-type="publisher-id">2294222</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>The landscape of alternative polyadenylation during EMT and its regulation by the RNA-binding protein Quaking</article-title><alt-title alt-title-type="left-running-head">D. P. NEUMANN ET AL.</alt-title><alt-title alt-title-type="right-running-head">RNA BIOLOGY</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Neumann</surname><given-names>Daniel P.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pillman</surname><given-names>Katherine A.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dredge</surname><given-names>B. Kate</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bert</surname><given-names>Andrew G.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Phillips</surname><given-names>Caroline A.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lumb</surname><given-names>Rachael</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ramani</surname><given-names>Yesha</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bracken</surname><given-names>Cameron P.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hollier</surname><given-names>Brett G.</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Selth</surname><given-names>Luke A.</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="aff0004" ref-type="aff">
<sup>d</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Beilharz</surname><given-names>Traude H.</given-names></name><xref rid="aff0005" ref-type="aff">
<sup>e</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Goodall</surname><given-names>Gregory J.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gregory</surname><given-names>Philip A.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><aff id="aff0001"><label>a</label>Centre for Cancer Biology, <institution-wrap><institution>University of South Australia and SA Pathology</institution></institution-wrap>, <city>Adelaide</city>, <state>SA</state>, <country>Australia</country></aff><aff id="aff0002"><label>b</label>Faculty of Health and Medical Sciences, <institution-wrap><institution>The University of Adelaide</institution></institution-wrap>, <city>Adelaide</city>, <state>SA</state>, <country>Australia</country></aff><aff id="aff0003"><label>c</label>Australian Prostate Cancer Research Centre - Queensland, Centre for Genomics and Personalised Health, Faculty of Health, School of Biomedical Sciences, <institution-wrap><institution>Queensland University of Technology</institution></institution-wrap>, <city>Brisbane</city>, <state>QLD</state>, <country>Australia</country></aff><aff id="aff0004"><label>d</label>Flinders Health and Medical Research Institute, <institution-wrap><institution>Flinders University</institution></institution-wrap>, <city>Bedford Park</city>, <state>SA</state>, <country>Australia</country></aff><aff id="aff0005"><label>e</label>Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, <institution-wrap><institution>Monash University</institution></institution-wrap>, <city>Melbourne</city>, <country>Australia</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT Philip A. Gregory <email xlink:href="mailto:philip.gregory@unisa.edu.au">philip.gregory@unisa.edu.au</email> Centre for Cancer Biology, <institution-wrap><institution>University of South Australia and SA Pathology</institution></institution-wrap>, <city>Adelaide</city>, <state>SA</state>
<postal-code>5000</postal-code>, <country>Australia</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>12</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>12</month><year>2023</year></pub-date><volume>21</volume><issue>1</issue><fpage seq="15">1</fpage><lpage>11</lpage><pub-history><event event-type="tagger"><event-desc>Integra</event-desc><date><day>18</day><month>12</month><year>2023</year></date></event><event event-type="final"><event-desc>Integra</event-desc><date><day>18</day><month>12</month><year>2023</year></date></event><event event-type="revised"><date><day>11</day><month>11</month><year>2023</year></date></event><event event-type="accepted"><date><day>05</day><month>12</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#x000a9; 2023 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="KRNB_21_2294222.pdf"/><abstract><title>ABSTRACT</title><p>Epithelial-mesenchymal transition (EMT) plays important roles in tumour progression and is orchestrated by dynamic changes in gene expression. While it is well established that post-transcriptional regulation plays a significant role in EMT, the extent of alternative polyadenylation (APA) during EMT has not yet been explored. Using 3&#x02019; end anchored RNA sequencing, we mapped the alternative polyadenylation (APA) landscape following Transforming Growth Factor (TGF)-&#x003b2;-mediated induction of EMT in human mammary epithelial cells and found APA generally causes 3&#x02019;UTR lengthening during this cell state transition. Investigation of potential mediators of APA indicated the RNA-binding protein Quaking (QKI), a splicing factor induced during EMT, regulates a subset of events including the length of its own transcript. Analysis of QKI crosslinked immunoprecipitation (CLIP)-sequencing data identified the binding of QKI within 3&#x02019; untranslated regions (UTRs) was enriched near cleavage and polyadenylation sites. Following QKI knockdown, APA of many transcripts is altered to produce predominantly shorter 3&#x02019;UTRs associated with reduced gene expression. These findings reveal the changes in APA that occur during EMT and identify a potential role for QKI in this process.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Quaking</kwd><kwd>epithelial-mesenchymal transition</kwd><kwd>alternative polyadenylation</kwd><kwd>Crosslinked immunopreciptation (CLIP) sequencing</kwd><kwd>3&#x02019; untranslated region (3&#x02019;UTR)</kwd><kwd>RNA binding protein (RBP)</kwd></kwd-group><support-group><funding-group><award-group><funding-source>
<institution-wrap><institution>Australian Research Council</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100000923</institution-id></institution-wrap>
</funding-source><award-id>FT180100049</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>Cancer Council South Australia</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100000950</institution-id></institution-wrap>
</funding-source><award-id>Principal Cancer Research Fellowship</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>National Breast Cancer Foundation</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100001026</institution-id></institution-wrap>
</funding-source><award-id>IIRS-18-147</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>National Health and Medical Research Council</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100000925</institution-id></institution-wrap>
</funding-source></award-group><award-group><funding-source>
<institution-wrap><institution>National Health and Medical Research Council</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100000925</institution-id></institution-wrap>
</funding-source></award-group><funding-statement>The work was supported by the&#x000a0;Australian Research Council [FT180100049]; Cancer Council South Australia [Principal Cancer Research Fellowship]; National Breast Cancer Foundation [IIRS-18-147]; National Health and Medical Research Council [1128479, 1164669, 1118170]; National Health and Medical Research Council [1128479,1164669].</funding-statement></funding-group></support-group><counts><fig-count count="4"/><ref-count count="54"/><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro" disp-level="1" id="s0001"><title>Introduction</title><p>Epithelial-mesenchymal transition (EMT) is a developmental process that facilitates cancer progression in epithelial-derived tumours, through the acquisition of mesenchymal features [<xref rid="cit0001" ref-type="bibr">1</xref>]. EMT can be initiated by extracellular cues that regulate extensive changes in gene transcription through induction of EMT transcription factors [<xref rid="cit0002" ref-type="bibr">2</xref>]. Of note, TGF-&#x003b2; signalling is a potent inducer of the transcription factors ZEB1 and ZEB2, which operate in a reciprocal feedback loop with miR-200 to drive dynamic changes in gene expression and cell state [<xref rid="cit0003" ref-type="bibr">3&#x02013;6</xref>]. EMT also involves widespread changes in alternative splicing mediated by specific RNA-binding proteins (RBP) [<xref rid="cit0007" ref-type="bibr">7&#x02013;10</xref>]. Recently, we and others identified a prominent role for the RBP Quaking (QKI) in promoting EMT-associated alternative splicing and the acquisition of mesenchymal cell traits through maintenance of mesenchymal splicing patterns [<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0012" ref-type="bibr">12</xref>]. QKI expression is elevated by loss of miR-200 during TGF-&#x003b2; driven EMT, where it binds to introns and results in the alternative splicing of hundreds of mRNA targets [<xref rid="cit0012" ref-type="bibr">12</xref>].</p><p>QKI is itself alternatively spliced to produce three major isoforms, QKI-5, QKI-6 and QKI-7, with distinct functions. By virtue of a nuclear localization signal, QKI-5 is localized in the nucleus, while QKI-6 and QKI-7 are predominantly expressed in the cytoplasm [<xref rid="cit0013" ref-type="bibr">13</xref>]. The nuclear QKI-5 isoform plays important roles in alternative splicing while the cytoplasmic QKI isoforms contribute to regulating many aspects of mRNA metabolism including mRNA stability, localization and translation [<xref rid="cit0014" ref-type="bibr">14&#x02013;19</xref>]. Consistent with these functions, a subset of QKI-binding occurs within 3&#x02019;UTRs during EMT [<xref rid="cit0012" ref-type="bibr">12</xref>]; however, it is currently unclear what the functional consequences of QKI 3&#x02019;UTR binding are in mesenchymal cells.</p><p>The influence of alternative cleavage and polyadenylation (APA) on transcript diversity during EMT is largely unexplored. APA can produce transcripts with varying 3&#x02019;UTRs or alterative last exons, which can impact mRNA stability, localisation, translation and in some cases regional translation of specific mRNAs [<xref rid="cit0020" ref-type="bibr">20</xref>]. RBPs can co-transcriptionally regulate APA leading to coordination of APA in a cell specific manner based on the relative expression or activities of these factors [<xref rid="cit0021" ref-type="bibr">21</xref>]. While 3&#x02019;UTR shortening is prevalent in solid cancers and can promote expression of oncogenes [<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0023" ref-type="bibr">23</xref>], broader comparisons of APA and gene expression changes show no consistent relationship, indicating that these two mechanisms of gene regulation operate largely independently [<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0025" ref-type="bibr">25</xref>].</p><p>Here, we performed 3&#x02019; end anchored RNA sequencing (PolyA-Test RNA-seq or PAT-Seq) to quantitate the landscape of APA during EMT. Following TGF-&#x003b2;-induced EMT of human mammary epithelial cells (HMLE), we identified 79 events with significant APA, two-thirds of which resulted in longer 3&#x02019;UTRs. By analysis of QKI CLIP-seq data, we identified a large proportion of QKI 3&#x02019;UTR binding occurs adjacent to productive cleavage and polyadenylation (CPA) sites and found QKI knockdown in mesenchymal HMLE (mesHMLE) cells generally shortens 3&#x02019;UTRs. These findings reveal the APA landscape during EMT and highlight a novel function for QKI as a regulator of APA.</p></sec><sec disp-level="1" id="s0002"><title>Results</title><sec disp-level="2" id="s0002-s2001"><title>Alternative polyadenylation events regulated during EMT and by loss of QKI</title><p>While it is well established that post-transcriptional regulation plays a significant role in EMT, the extent of APA during EMT has not yet been explored. As the identification of shifts in CPA site usage requires a 3`end anchored RNA-Seq method, we performed PAT-Seq [<xref rid="cit0026" ref-type="bibr">26</xref>,<xref rid="cit0027" ref-type="bibr">27</xref>] on triplicate samples of human mammary epithelial (HMLE) cells and HMLE cells treated with TGF-&#x003b2; for 20&#x02009;days to induce EMT (mesHMLE cells). We also performed PAT-seq on duplicate samples of mesHMLE cells transfected with siRNAs targeting QKI-5, a known regulator of alternative splicing in EMT, but with no recognized role in APA [<xref rid="cit0012" ref-type="bibr">12</xref>], generating on average&#x02009;~&#x02009;8 million mapped reads per sample (Supplementary Table S1). Multidimensional scaling analysis showed distinct clustering of each sample type (Supplementary Figure S1A and Supplementary Table S2). This technique enabled us to identify changes in CPA site usage and poly(A) tail length during EMT as well as those regulated by QKI.</p><p>We verified the induction of EMT in the mesHMLE samples by confirming downregulation of epithelial markers E-cadherin and ESRP1 and upregulation of mesenchymal markers ZEB1, Vimentin, N-cadherin, and QKI (Supplementary Figure S1C, Supplementary Table S3 and 4). Transfection of mesHMLE with the QKI-5 siRNA led to reduced expression of each of the major QKI isoforms (Supplementary Figure S1B, consistent with its known role in self-splicing its own transcript [<xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0029" ref-type="bibr">29</xref>]. Therefore, while QKI-5 is the predominant isoform in these cells, the QKI-5 siRNA treatment serves effectively as a total QKI knockdown as reflected in loss of total QKI protein (see <xref rid="f0002" ref-type="fig">Figure 2E</xref>). QKI knockdown did not change EMT markers, as previously observed (Supplementary Figure S1C) [<xref rid="cit0012" ref-type="bibr">12</xref>]. In each group of samples, the mean poly(A) tail length was similar indicating global changes in poly(A) tail length are not a feature of EMT or regulated by QKI (Supplementary Table S1). Likewise, tests for changes in poly (A) tail length of specific genes during EMT or after QKI knockdown did not uncover any significant events (Supplementary Table S5 and 6). In contrast, there were 79 genes with significantly affected APA during EMT, with 27 shortening events and 52 lengthening events (<xref rid="f0001" ref-type="fig">Figure 1A</xref>, Supplementary Table S7). QKI knockdown resulted in an opposing pattern of APA with 94 shortening and 25 lengthening events (total 119 genes, <xref rid="f0001" ref-type="fig">Figure 1B</xref>, Supplementary Table S8), suggesting QKI may promote a shift to distal CPA site usage during EMT. Examining the intersection in these datasets showed a small overlap between the statistically significant APA events (7 genes), although each of these events changed in opposing directions (Supplementary Figure S1D). These data suggest that QKI regulates a subset of APA events during EMT.
<fig position="float" id="f0001" fig-type="figure"><label>Figure 1.</label><caption><p>PAT-Seq uncovers widespread switching to distal cleavage sites after EMT and proximal sites after QKI knockdown. (A) MA plots for mesHMLE vs HMLE with APA effect size plotted against average expression across samples. (B) MA plot for mesHMLE vs mesHMLE&#x02009;+&#x02009;QKI knockdown. A positive effect size value indicates a shift to distal cleavage site usage, while a negative value indicates a shift to proximal sites. Blue dots indicate no significant change in APA, black dots indicate a significant change in APA and red dots indicate a significant change in APA and a QKI CLIP-Seq peak present in the 3&#x02019;UTR of that transcript (in at least 3 QKI CLIP-Seq replicates). (C) The most enriched motif in the mesHMLE HITS-CLIP as determined by the software package HOMER. (D) Pie chart showing the distribution of QKI CLIP-Seq peaks by genomic location type. (E) Volcano plot of enriched GO terms from the set of 443 transcripts bound by QKI in at least 4 out of 7 separate CLIP-Seq experiments. Dot colour and size represents number of overlapping genes for that category. (F) Pie chart depicting the proportion of QKI 3&#x02019;UTR targets with the QKI-CLIP peak centre within 100 nucleotides of an annotated cleavage site from the Poly A site atlas.</p></caption><alternatives><graphic xlink:href="KRNB_A_2294222_F0001_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KRNB_A_2294222_F0001_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig><fig position="float" id="f0002" fig-type="figure"><label>Figure 2.</label><caption><p>QKI 3&#x02019;UTR binding often occurs near cleavage and polyadenylation sites. (A) Heat map comparison of QKI regulated APA events with QKI CLIP-seq datasets to identify APA events directly regulated by QKI. Genes with APA events and evidence of QKI binding in at least 3 QKI CLIP-seq datasets are indicated (<italic toggle="yes">n</italic>&#x02009;=&#x02009;24). Where QKI binding sites are located within 100nt window either side of the APA site these are highlighted in bold. (B) Bar chart of enriched GO terms in the set of 24 genes. (C) Images of IGV tracks depicting change in cleavage site usage for selected genes. Individual tracks show depth-normalized coverage of each replicate PAT-Seq sample for HMLE, mesHMLE and mesHMLE&#x02009;+&#x02009;QKI knockdown. (D) Graphs showing the change in APA site usage for selected genes in HMLE (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4), mesHMLE (<italic toggle="yes">n</italic>&#x02009;=&#x02009;3), mesHMLE&#x02009;+&#x02009;QKI-5 knockdown (<italic toggle="yes">n</italic>&#x02009;=&#x02009;3) and mesHMLE&#x02009;+&#x02009;QKI-5 overexpression (<italic toggle="yes">n</italic>&#x02009;=&#x02009;3), as determined by qRT-PCRs. For WDFY3 and COMT, proximal cleavage primers detect proximal and distal APA and are a measure of total mRNA. Error bars indicate standard deviation of the mean. Statistical significance determined by performing a one-way ANOVA (F-value and p-value indicated) followed by Sidak&#x02019;s multiple comparison post-hoc test. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001. (E) Western blot of QKI-5 and Tubulin expression in representative samples from (D). (F) Scatter plot showing the ratio of the Long to short 3&#x02019;UTR transcripts against total QKI mRNA in the Cancer Cell Line Encyclopedia breast cancer samples [<xref rid="cit0035" ref-type="bibr">35</xref>]. Line represents a linear regression model and the shaded area represents the confidence interval. Pearson correlation coefficients and associated p-values are shown with p-values &#x0003c;0.05 highlighted in red.</p></caption><alternatives><graphic xlink:href="KRNB_A_2294222_F0002_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KRNB_A_2294222_F0002_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec><sec disp-level="2" id="s0002-s2002"><title>QKI binds near productive cleavage and polyadenylation sites</title><p>Previously, we uncovered numerous QKI binding sites within introns by performing QKI-5 HITS-CLIP on mesHMLE cells [<xref rid="cit0012" ref-type="bibr">12</xref>]. These sites reflect QKI&#x02019;s established role as a regulator of alternative splicing, where QKI-5 was found to directly bind and regulate alternative splicing of hundreds of mRNAs during EMT. However, a subset of peaks were found in 3&#x02019;UTRs, suggesting that QKI may regulate some mRNAs through non-splicing mechanisms.</p><p>CLIP-Seq results can be greatly affected by the choice of methods and antibodies, and the choice of peak calling requires the selection of parameters that strike a balance between sensitivity and stringency [<xref rid="cit0030" ref-type="bibr">30</xref>]. Therefore, we sought to generate a list of high confidence QKI 3&#x02019;UTR targets by pooling data from several QKI CLIP-Seq experiments. Along with our previously published QKI-5 HITS-CLIP in mesHMLE cells (rep-1) [<xref rid="cit0012" ref-type="bibr">12</xref>], we performed a second set of HITS-CLIP experiments using a combination of the same QKI-5 antibody and a panQKI antibody that recognizes all QKI isoforms (rep-2). This second QKI HITS-CLIP experiment is designed to capture all QKI isoforms and all potential 3&#x02019;UTR targets of QKI. Consistent with our previous observations [<xref rid="cit0012" ref-type="bibr">12</xref>], we identified the known QKI motif to be the most highly enriched sequence within the peaks (<xref rid="f0001" ref-type="fig">Figure 1C</xref>) and found the majority of QKI binding occurred within introns (<xref rid="f0001" ref-type="fig">Figure 1D</xref>).</p><p>In this second QKI HITS-CLIP experiment, we identified 429 distinct mRNAs with QKI peaks within 3&#x02019;UTR suggesting that QKI could regulate these transcripts (Supplementary Table S9). Compared with the QKI-5 HITS-CLIP rep-1, we observed an overlap of 157 peaks within 3&#x02019;UTRs, which may be indicative of false positive or negative peaks or cytoplasmic-specific QKI interactions since the panQKI antibody recognizes both cytoplasmic and nuclear isoforms of QKI (Supplementary Figure S2A). To generate a list of higher confidence QKI 3&#x02019;UTR targets, we expanded our analysis to include various published QKI CLIP-seq datasets. We analysed data from PAR-CLIP performed on HEK293 human embryonic kidney cells (PAR-CLIP-HEK293) and eCLIP performed on K562 chronic myelogenous leukemia cells (K562-rep-1 and K562-rep-2) and HepG2 hepatocellular carcinoma cells (HEPG2-rep-1 and HEPG2-rep-2) [<xref rid="cit0031" ref-type="bibr">31</xref>,<xref rid="cit0032" ref-type="bibr">32</xref>], constraining our analysis to peaks called within 3&#x02019;UTRs (Supplementary Figure S2A). Using these datasets, we generated a unique list of regions that overlap with a peak in at least one QKI CLIP-Seq experiment (Supplementary Table S10). We subsequently tallied the number of experiments where a peak was successfully called for each unique region, and shortlisted regions containing a peak in at least four out of the seven experiments. This resulted in the identification of 622 peak-containing regions that were present within 443 distinct transcripts (Supplementary Table S10). To determine if these genes have functions that are relevant to epithelial plasticity, we performed gene ontology (GO) analysis and uncovered pathways related to EMT-associated properties, including cell junctions and focal adhesions (<xref rid="f0001" ref-type="fig">Figure 1E</xref>), supporting the notion that regulation of these mRNAs by QKI might be functionally important.</p><p>Next, we explored whether QKI binding within 3&#x02019;UTRs may be involved in regulating APA. Recent analysis of the cytoplasmic isoform, QKI-6, found an enrichment of binding within 3&#x02019;UTRs adjacent to the polyA signal (PAS) [<xref rid="cit0017" ref-type="bibr">17</xref>]. As the QKI isoforms share the same RNA-binding domain and recognize the same RNA-binding motif [<xref rid="cit0033" ref-type="bibr">33</xref>], we speculated that the nuclear isoform, QKI-5, might also bind near PAS and affect CPA. To assess this possibility, we compared the QKI CLIP-Seq data to the PolyA site atlas [<xref rid="cit0034" ref-type="bibr">34</xref>] to identify peaks that occur near productive CPA clusters. Of the 443 QKI 3&#x02019;UTR targets, approximately half had annotated CPA sites within or nearby a QKI CLIP-Seq peak (<xref rid="f0001" ref-type="fig">Figure 1F</xref>). Although there was variability in the QKI CLIP-seq datasets, several of these showed QKI binding was primarily enriched in close proximity to the CPA site (Supplementary Figure S2B). These results suggest that a large proportion of QKI 3&#x02019;UTR-binding occurs at productive CPA sites and uncovers a putative role for QKI in regulating alternative polyadenylation.</p></sec><sec disp-level="2" id="s0002-s2003"><title>A subset of alternative polyadenylation during EMT is controlled by QKI</title><p>To uncover APA events directly regulated by QKI, we compared the genes with altered APA after QKI knockdown to QKI 3&#x02019;UTR CLIP-seq targets, identifying 24 genes that had altered APA and evidence of QKI binding in at least 3 separate experiments. This overlap was highly significant (<italic toggle="yes">P</italic>&#x02009;=&#x02009;1.05&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;9</sup>, hypergeometric test), suggesting QKI directly regulates APA of this subset of mRNAs (<xref rid="f0002 f0001" ref-type="fig">Figures 2A and 1B</xref>). Gene ontology (GO) of these genes highlighted processes including lamellipodium, fibroblast migration and cell leading edge, indicating that QKI-regulated APA may contribute to changes in cell migration (<xref rid="f0002" ref-type="fig">Figure 2B</xref>), a feature prominently regulated by QKI in mesenchymal cells [<xref rid="cit0012" ref-type="bibr">12</xref>].</p><p>To validate the findings of the PAT-Seq, we performed qRT-PCR on select candidate genes with significantly altered APA during EMT or following QKI knockdown (<xref rid="f0002" ref-type="fig">Figure 2C</xref>). We also included the gene TTF2 that, although not significantly altered in the PAT-seq data, had strong evidence of QKI binding near to a productive CPA site. To detect a switch between mRNA isoforms with different cleavage sites within the same 3&#x02019;UTR, we designed a primer set specific for the longer 3&#x02019;UTR and another set that amplifies a common region. For cleavage sites in distinct 3&#x02019;UTRs, we designed primers that were specific for each isoform. We found several genes with consistently altered APA after EMT, that changed in the opposite direction after QKI knockdown or were augmented after QKI-5 overexpression in mesHMLE cells, consistent with QKI controlling the choice between the alternative CPA sites (<xref rid="f0002" ref-type="fig">Figure 2D,E</xref>).</p><p>To determine whether the effects of QKI on APA occur more broadly, we examined expression of long and short 3&#x02019;UTR isoforms of our candidate genes in breast cancer cell lines within the Cancer Cell Line Encyclopaedia [<xref rid="cit0035" ref-type="bibr">35</xref>]. Of the six transcripts where long and short 3&#x02019;UTR are annotated, we found significant positive correlations between the ratio of long to short 3&#x02019;UTR transcript and <italic toggle="yes">QKI-5</italic> mRNA for five of these suggesting that the balance between the long and 3&#x02019;UTRs of these genes is dependent on QKI expression (<xref rid="f0002" ref-type="fig">Figure 2F</xref>).</p></sec><sec disp-level="2" id="s0002-s2004"><title>QKI regulates alternative polyadenylation of its own transcript</title><p>Among the QKI-regulated APA genes, we identified two CLIP-seq peaks within the <italic toggle="yes">QKI</italic> transcript itself that overlapped canonical QKI-binding motifs and were located immediately downstream from an annotated CPA site for QKI-5 (<xref rid="f0003" ref-type="fig">Figure 3A</xref>). This region encompasses three distinct polyadenylation signals, one of which appears to be the predominant signal for polyadenylation of QKI-5 (<xref rid="f0003" ref-type="fig">Figure 3B</xref>). When examining the <italic toggle="yes">QKI-5</italic> 3&#x02019;UTR in the UCSC genome browser, we found that many expressed sequence tags (ESTs) ended at the short 3&#x02019;UTR terminus (QKI-5-Short) identified previously [<xref rid="cit0012" ref-type="bibr">12</xref>] or&#x02009;~&#x02009;2kb upstream, with a smaller number ending at the annotated long 3&#x02019;UTR terminus (QKI-5-Long) (Supplementary Figure S3A). At the QKI-5-Short terminus, the majority of ESTs ended at the QKI binding site downstream of the predominant PAS (Supplementary Figure S3B), which lead us to hypothesize that QKI may repress cleavage and polyadenylation at this location and utilize a downstream PAS to generate a longer QKI-5 3&#x02019;UTR.
<fig position="float" id="f0003" fig-type="figure"><label>Figure 3.</label><caption><p>QKI-5 regulates its own APA to produce a transcript with a long 3&#x02019;UTR. (A) IGV tracks depicting the location of QKI CLIP-Seq peaks in the QKI-5 3&#x02019;UTR. (B) The nucleotide sequence around the predominant site of QKI binding in the QKI-5 3&#x02019;UTR showing potential QKI binding and PAS sites. (C-E) Bar charts depicting the ratio of the isoform that uses the distal cleavage site to the isoform that uses the proximal cleavage sites for indicated genes determined by qRT-PCRs performed on mesHMLE, mesHMLE QKI knockout and mesHMLE QKI Knockout&#x02009;+&#x02009;inducible QKI-5, with and without 1&#x02009;&#x000b5;g/mL doxycycline (Dox) treatment (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1), (G-I) and PC3-eLuc-GFP, PC3-eLuc-GFP QKI knockout and PC3-eLuc-GFP QKI knockout&#x02009;+&#x02009;inducible QKI-5 (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1). (F &#x00026; J) Western blots of QKI and Tubulin protein performed on matched protein samples for (C-E &#x00026; G-I).</p></caption><alternatives><graphic xlink:href="KRNB_A_2294222_F0003_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KRNB_A_2294222_F0003_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p><p>To confirm the existence of a <italic toggle="yes">QKI-5</italic> transcript with a longer 3&#x02019;UTR and determine if QKI-5 protein induces its production, we examined expression of the QKI-5-Short and QKI-5-Long in a mesHMLE clonal cell line with CRISPR-generated QKI knockout. These cells had reduced QKI protein expression but retained QKI-5 mRNA, allowing us to modulate QKI-5 protein levels by exogenous expression and measure effects on endogenous QKI-5 mRNA. We transduced this cell line with a doxycycline-inducible QKI-5 expression construct and measured QKI-5-long and total QKI in wild-type mesHMLE, QKI knockout, and in QKI knockout cells with and without QKI-5 overexpression. Reduced QKI-5 protein in the knockout cells led to decreased production of QKI-5-Long mRNA, but not total endogenous QKI-5 mRNA, and a consequent decrease in distal to proximal PAS usage (Supplementary Figure S4A and 4C, <xref rid="f0003" ref-type="fig">Figure 3C,F</xref>). In contrast, overexpression of QKI-5 increased QKI-5-long while reducing total endogenous QKI-5 mRNA, leading to an increase in the distal to proximal PAS usage (Supplementary Figure S4A and 4C, <xref rid="f0003" ref-type="fig">Figure 3C,F</xref>). In these samples, we also verified that the proportion of distal to proximal PAS usage for Catechol-O-methyltransferase (<italic toggle="yes">COMT</italic>) and Transcription Termination Factor 2 (<italic toggle="yes">TTF2</italic>) are also influenced by QKI levels as observed previously (<xref rid="f0003" ref-type="fig">Figure 3D,E</xref>). To determine whether QKI autoregulation of 3&#x02019;UTR length occurs in other contexts, we generated a second series of cell lines with the same QKI manipulations in the prostate cancer cell line PC-3. Similar to mesHMLE cells, we found QKI knockout reduced the distal to proximal PAS usage of QKI-5 and TTF2, while QKI-5 overexpression increased the distal to proximal PAS usage of QKI-5, TTF2 and COMT (<xref rid="f0003" ref-type="fig">Figures 3G-J</xref>, Supplementary Figure S4B and 4D). Collectively, these findings indicate that QKI-5 regulates its own APA, and the APA of other genes, to generate isoforms with generally longer 3&#x02019;UTRs during EMT.</p></sec><sec disp-level="2" id="s0002-s2005"><title>QKI regulated APA increases 3&#x02019;UTR length and gene expression</title><p>To investigate the potential consequences of APA during EMT, we examined the relationship of APA to gene expression changes. While EMT was associated with large changes in gene expression (2203 genes, FDR&#x02009;&#x0003c;&#x02009;0.05, Supplementary Figure S5A and Supplementary Table S3), only modest numbers of genes change expression following QKI knockdown (101 genes, FDR&#x02009;&#x0003c;&#x02009;0.05, Supplementary Figure S5B and Supplementary Table S4), consistent with previous observations [<xref rid="cit0012" ref-type="bibr">12</xref>]. As the number of genes with significant expression changes in the QKI knockdown set was modest, we assessed the potential relationship between APA and gene expression using the top 50 differentially expressed genes that also had significant changes in APA. During EMT, while APA generally caused 3&#x02019;UTR lengthening there was no consistent relationship between gene expression and APA (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.32, <xref rid="f0004" ref-type="fig">Figure 4A,C</xref>). In contrast, QKI knockdown predominantly caused 3&#x02019;UTR shortening and repression of gene expression (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.002, <xref rid="f0004" ref-type="fig">Figure 4B,D</xref>). Collectively, these data suggest that QKI regulates a subset of genes during EMT associated with altered 3&#x02019;UTR length.
<fig position="float" id="f0004" fig-type="figure"><label>Figure 4.</label><caption><p>Correlation of APA changes with gene expression changed during EMT and following QKI knockdown. (A-B) Changes in APA during EMT of HMLE cells or following QKI knockdown in mesHMLE cells, aligned from most shortened to most lengthened 3&#x02019;UTR. Only the top 50 differentially expressed genes with significant changes in APA (FDR &#x0003c;0.05) are represented (C-D) Corresponding changes in gene expression for APA affected genes. Blue bars indicate decreased APA and gene expression, and red bars indicate increased APA and gene expression. Statistical significance was measured using a one sample t-test on differentially expressed genes with significant APA change with mean expression change, confidence interval, and p-values shown.</p></caption><alternatives><graphic xlink:href="KRNB_A_2294222_F0004_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="KRNB_A_2294222_F0004_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec></sec><sec disp-level="1" id="s0003"><title>Discussion</title><p>To our knowledge, this study represents the first targeted examination of alternative polyadenylation (APA) during EMT using 3&#x02019; end anchored RNA sequencing. Here, we have shown that many transcripts display APA after EMT in human mammary epithelial cells, and present evidence that the mesenchymal splicing factor QKI regulates APA of several transcripts during EMT, including its own, to produce mRNAs with distinct 3&#x02019;UTRs or last exons. This supports the existence of a mesenchymal-specific APA signature that QKI contributes to and warrants further investigation of how widespread this mode of regulation is in other contexts of EMT and cellular differentiation regulated by QKI [<xref rid="cit0016" ref-type="bibr">16</xref>].</p><p>With the PAT-seq method, we detected many APA events (~200) that were regulated during EMT and/or directly by QKI. While there was a small overlap between EMT and QKI knockdown regulated APA events, this is not entirely unexpected given that APA can be influenced by many RBPs, including those that are regulated during EMT [<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0036" ref-type="bibr">36</xref>]. However, validation of APA events by qPCR indicates that a larger fraction may be regulated in opposing directions in both scenarios. For instance, while the ratio of the long to short 3&#x02019;UTRs of COMT and TTF2 increased during EMT and responded to QKI manipulation, these ratios were not significantly changed in the EMT PAT-seq dataset. This highlights limitations of the sensitivity of PAT-seq at the sequencing depth reported here (5&#x02013;10 million reads per sample mapping to the genome).</p><p>While many APA events were detected to be regulated by QKI, we constrained our analysis to events where direct evidence for QKI 3&#x02019;UTR binding was observed. Gene Ontology of this select gene subset revealed enrichment of EMT-associated properties indicating APA may cause functional changes consequential for EMT. For example, both Inverted Formin 2 (INF2) and Erythrocyte Membrane Protein Band 4.1 Like 5 (EBP41L5) have reported functions in controlling focal adhesion and actin dynamics that are important for cell migration [<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0038" ref-type="bibr">38</xref>]. Discovery of how these alternative 3&#x02019;UTR sequences affect gene expression during EMT warrants further study.</p><p>During EMT, approximately two-thirds of APA events were associated with 3&#x02019;UTR lengthening, while the opposite pattern occurred upon QKI knockdown in mesenchymal cells. Examination of the mRNA levels of APA-regulated transcripts during EMT revealed no correlation between gene expression and APA. In contrast, QKI knockdown generally decreased the expression of mRNAs whose APA it directly affected. Given QKI knockdown only influenced overall gene expression modestly, this suggests QKI-regulated APA may play a prominent role in generating more stable mRNA transcripts. Alternatively, as the binding of cytoplasmic forms of QKI is known to regulate the stability of specific transcripts [<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0019" ref-type="bibr">19</xref>,<xref rid="cit0039" ref-type="bibr">39</xref>,<xref rid="cit0040" ref-type="bibr">40</xref>], QKI may influence both APA and mRNA stability through different mechanisms. Although APA-induced 3&#x02019;UTR shortening is a feature of cancer cells and can induce oncogene expression [<xref rid="cit0022" ref-type="bibr">22</xref>], broad associations between APA and gene expression are generally not observed [<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0025" ref-type="bibr">25</xref>,<xref rid="cit0041" ref-type="bibr">41</xref>]. APA and associated changes in 3&#x02019;UTR usage can alter the localization and local translation of mRNA transcripts [<xref rid="cit0042" ref-type="bibr">42</xref>]. Considering the dynamic nature of epithelial plasticity, and the observation that altered protein localization can drive features of EMT in cancer [<xref rid="cit0043" ref-type="bibr">43</xref>], it may be that changes in APA of these mRNAs change the fate of their coded proteins, with potential consequences for protein folding, complex formation and localization. Indeed, protein complex formation and localization have been suggested to be 3&#x02019;UTR-directed, with the long 3&#x02019;UTR variant of Cluster of Differentiation 47 (CD47) specifically, interacting with SET Nuclear Proto-Oncogene (SET) protein and localizing it to the plasma membrane [<xref rid="cit0044" ref-type="bibr">44</xref>]. Further research is needed to determine what the functional consequences of QKI-directed APA are to the target mRNAs coded protein.</p><p>While the finding that QKI regulates its own APA has not been previously reported, the ability of QKI to self-regulate is known [<xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0029" ref-type="bibr">29</xref>]. Indeed, the tendency of RBPs to auto-regulate is a well-established phenomenon, and auto-regulation of APA has been reported for other proteins of this class [<xref rid="cit0045" ref-type="bibr">45</xref>]. Whether QKI alternative polyadenylation serves as a mechanism of negative feedback or the switch to a longer 3&#x02019;UTR affects the localization or function of QKI protein will require further investigation.</p><p>In summary, we have uncovered a novel role for QKI in regulating APA of a subset of transcripts during EMT. Along with its function in regulating EMT associated alternative splicing [<xref rid="cit0012" ref-type="bibr">12</xref>], these data demonstrate the diverse roles of QKI in regulating transcript maturation during EMT.</p></sec><sec disp-level="1" id="s0004"><title>Materials and Methods</title><sec disp-level="2" id="s0004-s2001"><title>Cell culture</title><p>The immortalized human mammary epithelial cell line (HMLE) was cultured in HuMEC Ready Media (ThermoFisher) with HuMEC Supplement Kit (ThermoFisher) and passaged at a 1:5 ratio every 72&#x02009;hours. The TGF-&#x003b2;-treated mammary epithelial cell line (mesHMLE) was derived by culturing immortalized human mammary epithelial cells (HMLE) in mesHMLE culturing media (DMEM/F12- Dulbecco&#x02019;s Modified Eagle Medium: Nutrient Mixture F-12 supplemented with 5% Foetal Bovine Serum, 20&#x02009;ng/ml EGF, 10&#x02009;&#x003bc;g/ml insulin and 0.5&#x02009;&#x003bc;g/ml hydrocortisone) with 2.5 ng/&#x003bc;L TGF-&#x003b2;1 for at least 14&#x02009;days [<xref rid="cit0046" ref-type="bibr">46</xref>]. Once established, mesHMLE and mesHMLE QKI KO cells were all cultured in mesHMLE culturing media and passaged at a 1:10 ratio every 72&#x02009;hours. PC-3 cells were grown in RPMI-1640 media supplemented with 10% Foetal Bovine Serum.</p></sec><sec disp-level="2" id="s0004-s2002"><title>Generation of QKI knockout and overexpression cell lines</title><p>QKI knockout cells were generated by CRISPR-Cas9 gene editing. For mesHMLE cells, a guide RNA sequence designed to target the first exon of the QKI gene (Supplementary Table 11) was combined with tracrRNA and Cas9 protein (Integrated DNA Technologies, AltR system) according to the manufacturer&#x02019;s protocol and transfected using Lipofectamine RNAiMAX (ThermoFisher). Single clones were isolated following 72&#x02009;hr of culture and screened for loss of QKI protein by Western Blot. For PC-3 cells, a QKI ko clone was derived after transfection of a LentiCRISPRv2 vector containing a BsmBI cloned gRNA targeting the first exon of QKI (Supplementary Table 11) and isolation of single clones following puromycin selection. QKI-5 overexpression cells were generated by transduction of mesHMLE and PC-3 wild-type or QKI ko cells, with either a pLX301-QKI-5 or pInducer20-QKI-5 lentivirus generated as previously described [<xref rid="cit0012" ref-type="bibr">12</xref>].</p></sec><sec disp-level="2" id="s0004-s2003"><title>Transfection of siRNAs</title><p>Transfections in this study were carried out with 20&#x02009;nM of siRNA using Lipofectamine RNAiMAX and performed according to the manufacturer&#x02019;s protocol (ThermoFisher). Transfection media was removed the following day after transfection and cellular material was harvested 72&#x02009;hours after transfection. For PAT-seq samples, we used three untransfected replicates of HMLE cells, one untransfected (R1) and two negative control siRNAs (R2 and R3) replicates of mesHMLE cells, and two QKI-5 siRNA transfected replicates of mesHMLE cells. Sequences of siRNAs are provided in Supplementary Table 12.</p></sec><sec disp-level="2" id="s0004-s2004"><title>RNA isolation, cDNA synthesis and qRT-PCR</title><p>RNA was extracted using Trizol (ThermoFisher) following the standard manufacturer&#x02019;s protocol. Complementary DNA was synthesized from 1&#x02009;&#x003bc;g of RNA using the QuantitTect RT kit (Qiagen). Quantitative PCRs (qPCR) were performed in triplicate using the QuantiTect SYBR Green reagent (Qiagen) on a Rotor-Gene 6000 series thermocycler (Qiagen). Analysis was performed using the comparative quantitation feature in the Rotor-Gene software and qPCR assays were normalized to GAPDH expression to determine relative mRNA expression. To determine the proportion of distal polyadenylation site (PAS) usage for a given gene, the expression of the distal isoform is divided by the total expression of the gene. Sequences for the oligonucleotides used in the study are listed in Supplementary Table 11.</p></sec><sec disp-level="2" id="s0004-s2005"><title>Protein lysate purification and western blotting</title><p>Protein extracts were obtained by lysis of cells in 1&#x000d7;RIPA buffer (Abcam) containing cOmplete Mini, EDTA-free Protease inhibitor Cocktail tablets (Roche) and phosphatase (PhosSTOP EASYpack (Roche) inhibitors. Twenty micrograms of lysate were separated on an Invitrogen Bolt Bis-Tris Plus gel (Life Technologies), transferred to nitrocellulose, and probed with &#x003b1;-Tubulin (Abcam, ab7291), &#x003b1;-QKI-5 (Bethyl, A300-183A) or &#x003b1;-panQKI (Neuromab, N147/6) antibodies diluted 1:5000 in 5% skim milk. Proteins were detected by enhanced chemiluminescence (ECL) reagent (Pierce) using the ChemiDoc imaging system (Bio-Rad).</p></sec><sec disp-level="2" id="s0004-s2006"><title>QKI HITS-CLIP</title><p>The QKI-CLIP method was adapted from published methods [<xref rid="cit0047" ref-type="bibr">47</xref>], incorporating modifications from eCLIP [<xref rid="cit0032" ref-type="bibr">32</xref>] and iCLIP [<xref rid="cit0048" ref-type="bibr">48</xref>]. In brief, QKI was immunoprecipitated with a QKI-5 specific (Bethyl, A300-183A) or panQKI (Neuromab, N147/6) antibodies from crosslinked mesHMLE cells and sequencing libraries were prepared as detailed in the Supplementary Methods.</p></sec><sec disp-level="2" id="s0004-s2007"><title>PolyA-Test RNA-seq (PAT-seq)</title><p>PAT-seq libraries were prepared using 1 ug of total RNA as previously described [<xref rid="cit0026" ref-type="bibr">26</xref>,<xref rid="cit0027" ref-type="bibr">27</xref>]. Libraries were sequenced multiplexed on the Illumina NovaSeq 6000 instrument (Alfred Research Alliance Genomics Facility). Raw data was processed using the tail-tools pipeline [<xref rid="cit0026" ref-type="bibr">26</xref>]. The data from all samples was combined to identify 25,437 peaks associated with non-templated poly A-tracts. Of these 20,928 peaks and 73.3% of reads were in a 3&#x02019; UTR, 1349 peaks and 16.1% of reads were otherwise in an exon, 1202 peaks and 3.8% of reads were downstream of a non-coding RNA, 957 peaks and 0.7% of reads were in an intron, 403 peaks and 0.2% of reads otherwise antisense to a gene, 598 peaks and 5.8% of reads could not be related to annotated genes. Peaks were allowed up to 2000 bases downstream of the annotated 3&#x02019;UTR end, but not inside another gene on the same strand. Statistically significant changes to gene expression, poly (A) tail-length and APA were calculated as previously described [<xref rid="cit0049" ref-type="bibr">49</xref>].</p></sec><sec disp-level="2" id="s0004-s2008"><title>Bioinformatic analyses</title><p>Bioinformatics for QKI HITS-CLIP was performed essentially as previously described [<xref rid="cit0012" ref-type="bibr">12</xref>] and detailed in Supplementary Methods. In brief, BAM files for samples that were prepared using the QKI-5 specific and panQKI antibodies were pooled together by strand. Peak calling was performed using the MACS2 with a cut off fold-enrichment value of 3 and a cut-off q value of 0.05 [<xref rid="cit0050" ref-type="bibr">50</xref>]. Motif analysis was performed using HOMER [<xref rid="cit0051" ref-type="bibr">51</xref>].</p><p>Publicly available QKI CLIP data [<xref rid="cit0012" ref-type="bibr">12</xref>,<xref rid="cit0031" ref-type="bibr">31</xref>,<xref rid="cit0032" ref-type="bibr">32</xref>] was used to generate the list of high confidence QKI-binding sites within 3&#x02019;UTRs. The PolyA site atlas 2.0 [<xref rid="cit0034" ref-type="bibr">34</xref>] was used to identify productive cleavage and polyadenylation sites near QKI-binding sites. For coverage plots of QKI binding, the 3&#x02019;UTR peaks for each QKI CLIP-seq dataset were plotted for the 1000nt spanning the highest expressed CPA in the PolyA site atlas (based on transcripts per million). The coverage plots of QKI binding were produced by selecting the 3&#x02019;UTRs for each of the QKI 3&#x02019;UTR peaks represented in each QKI CLIP-seq dataset. The highest expressed CPA in the PolyA site atlas (based on transcripts per million) for each 3&#x02019;UTR was identified and QKI binding coverage was plotted for 500nt either side of the CPA.</p><p>Plots were generated using the Python packages Matplotlib and Seaborn, or GraphPad Prism. Motif logo figure was generated using the R package motifStack. Genome track figures were generated using Integrated Genomics Viewer [<xref rid="cit0052" ref-type="bibr">52</xref>] or the University of Santa Cruz Genome Browser [<xref rid="cit0053" ref-type="bibr">53</xref>].</p><p>Gene ontology analysis was performed using the tool WEB-based GEne SeT AnaLysis Toolkit (WebGestalt) using Over-Representation Analysis with the databases Biological Process, Cellular Component and Molecular Function [<xref rid="cit0054" ref-type="bibr">54</xref>].</p><p>Expression of the long and short 3&#x02019;UTR transcripts of EPB41L5, PEA15, INF2, COL12A1, COMT and TTF2, and QKI-5 mRNA were obtained from the Cancer Cell Line Encyclopedia breast cancer samples [<xref rid="cit0035" ref-type="bibr">35</xref>]. The identities of the long and short 3&#x02019;UTR transcript were determined by inspection of the Ensembl genome browser, with the transcripts used shown in Supplementary Table 13. Scatterplots were generated using the Python package, Seaborn, and Pearson correlation coefficients with associated <italic toggle="yes">P</italic> values were calculated using the Python package SciPy.</p></sec><sec disp-level="2" id="s0004-s2009"><title>Statistical analyses</title><p>A hypergeometric test was performed using the hypergeom.sf() function in the Python module scipy.stats to test for significant overlap between genes with QKI peaks and genes with APA in the PAT-Seq. This statistic takes into account the total number of expressed transcripts, which was determined to be 16,007 by counting the number of transcripts with a read count greater than 0 in the HMLE or mesHMLE RNA-Seq.</p><p>To test the changes in Distal PAS usage detected by qRT-PCR for statistical significance an ordinary 1-way ANOVA (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) was performed on all samples for each APA event followed by a Sidak&#x02019;s multiple comparison post-hoc test using GraphPad PRISM software.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="SM4948" position="float" content-type="local-data"><caption><title>Supplemental Material</title></caption><media xlink:href="KRNB_A_2294222_SM4948.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0807" position="float" content-type="local-data"><caption><title>Supplemental_Fig_S1.pdf</title></caption><media xlink:href="KRNB_A_2294222_SM0807.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0806" position="float" content-type="local-data"><caption><title>Supplementary_Table_10.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0806.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0805" position="float" content-type="local-data"><caption><title>Supplementary_Table_9.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0805.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0804" position="float" content-type="local-data"><caption><title>Supplementary Table 3.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0804.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0803" position="float" content-type="local-data"><caption><title>Supplementary_Table_4.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0803.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0802" position="float" content-type="local-data"><caption><title>Supplementary_Table_5.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0802.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0801" position="float" content-type="local-data"><caption><title>Neumann_SuppMethods.docx</title></caption><media xlink:href="KRNB_A_2294222_SM0801.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0800" position="float" content-type="local-data"><caption><title>Supplementary_Table_7.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0800.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0799" position="float" content-type="local-data"><caption><title>Supplementary_Table_12.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0799.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0798" position="float" content-type="local-data"><caption><title>Supplemental_Fig_S5.pdf</title></caption><media xlink:href="KRNB_A_2294222_SM0798.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0797" position="float" content-type="local-data"><caption><title>Supplemental_Fig_S2.pdf</title></caption><media xlink:href="KRNB_A_2294222_SM0797.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0796" position="float" content-type="local-data"><caption><title>Neumann_SuppTables.xlsx</title></caption><media xlink:href="KRNB_A_2294222_SM0796.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0795" position="float" content-type="local-data"><caption><title>Supplementary_Table_2.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0795.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0794" position="float" content-type="local-data"><caption><title>Supplementary_Table_13.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0794.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0793" position="float" content-type="local-data"><caption><title>Supplementary_Table_11.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0793.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0792" position="float" content-type="local-data"><caption><title>Supplemental_Fig_S4.pdf</title></caption><media xlink:href="KRNB_A_2294222_SM0792.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0791" position="float" content-type="local-data"><caption><title>Neumann_SuppTables.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0791.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0790" position="float" content-type="local-data"><caption><title>Supplementary_Table_8.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0790.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0789" position="float" content-type="local-data"><caption><title>Supplementary_Table_1.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0789.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM0788" position="float" content-type="local-data"><caption><title>Supplementary_Table_6.xls</title></caption><media xlink:href="KRNB_A_2294222_SM0788.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>We acknowledge the assistance of Angavai Swaminathan for PAT-seq library preparation, and Paul Harrison and the Monash Bioinformatics Platform for PAT-seq data management. This work was supported by grants from the National Health and Medical Research Council of Australia to P.A.G. and G.J.G. (1128479, 1164669), the National Breast Cancer Foundation (IIRS-18-147) and the Hospital Research Foundation. T.H.B. is supported by the ARC (FT180100049). G.J.G is supported by a National Health and Medical Research Council fellowship (1118170). P.A.G. and L.A.S. are supported by Principal Cancer Research Fellowships awarded by Cancer Council&#x02019;s Beat Cancer project on behalf of its donors, the state Government through the Department of Health, and the Australian Government through the Medical Research Future Fund.</p></ack><sec sec-type="COI-statement" disp-level="1" id="s0005"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec disp-level="1" id="s0006"><title>Author contributions</title><p>D.P.N and P.A.G conceived the project. D.P.N., B.K.D., A.G.B., C.A.P., R.L., Y.R., T.H.B. and P.A.G. performed experiments. D.P.N. and K.A.P. performed the bioinformatic analysis. C.P.B, B.G.H., L.A.S., G.J.G., and P.A.G. supervised the project. D.P.N. and P.A.G. wrote the manuscript with input from the supervisory team. All authors read and approved the final manuscript.</p></sec><sec disp-level="1" id="s0007"><title>Data deposition</title><p>The PAT-seq data and QKI HITS-CLIP data have been deposited into the Gene Expression Omnibus (GEO) with accession number GSE228932.</p></sec><sec sec-type="supplementary-material" disp-level="1" id="s0008"><title>Supplementary material</title><p>Supplemental data for this article can be accessed online at <ext-link xlink:href="https://doi.org/10.1080/15476286.2023.2294222" ext-link-type="uri">https://doi.org/10.1080/15476286.2023.2294222</ext-link></p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Antin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Berx</surname>
<given-names>G</given-names></string-name>, et al</person-group>. <article-title>Guidelines and definitions for research on epithelial&#x02013;mesenchymal transition</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2020</year>;<volume>21</volume>(<issue>6</issue>):<fpage>341</fpage>&#x02013;<lpage>352</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41580-020-0237-9</pub-id><pub-id pub-id-type="pmid">32300252</pub-id>
</mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Craene</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Berx</surname>
<given-names>G.</given-names></string-name></person-group>
<article-title>Regulatory networks defining EMT during cancer initiation and progression</article-title>. <source>Nat Rev Cancer</source>. <year>2013</year>;<volume>13</volume>(<issue>2</issue>):<fpage>97</fpage>&#x02013;<lpage>110</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrc3447</pub-id><pub-id pub-id-type="pmid">23344542</pub-id>
</mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bracken</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Gregory</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Kolesnikoff</surname>
<given-names>N</given-names></string-name>, et al</person-group>. <article-title>A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition</article-title>. <source>Cancer Res</source>. <year>2008</year>;<volume>68</volume>(<issue>19</issue>):<fpage>7846</fpage>&#x02013;<lpage>7854</lpage>. doi: <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1942</pub-id><pub-id pub-id-type="pmid">18829540</pub-id>
</mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burk</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Schubert</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wellner</surname>
<given-names>U</given-names></string-name>, et al</person-group>. <article-title>A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells</article-title>. <source>EMBO Rep</source>. <year>2008</year>;<volume>9</volume>(<issue>6</issue>):<fpage>582</fpage>&#x02013;<lpage>589</lpage>. doi: <pub-id pub-id-type="doi">10.1038/embor.2008.74</pub-id><pub-id pub-id-type="pmid">18483486</pub-id>
</mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gregory</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Bert</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Paterson</surname>
<given-names>EL</given-names></string-name>, et al</person-group>. <article-title>The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1</article-title>. <source>Nat Cell Biol</source>. <year>2008</year>;<volume>10</volume>(<issue>5</issue>):<fpage>593</fpage>&#x02013;<lpage>601</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ncb1722</pub-id><pub-id pub-id-type="pmid">18376396</pub-id>
</mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gregory</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Bracken</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>E</given-names></string-name>, et al</person-group>. <article-title>An autocrine TGF-&#x003b2;/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition</article-title>. <source>MBoC</source>. <year>2011</year>;<volume>22</volume>(<issue>10</issue>):<fpage>1686</fpage>&#x02013;<lpage>1698</lpage>. doi: <pub-id pub-id-type="doi">10.1091/mbc.e11-02-0103</pub-id><pub-id pub-id-type="pmid">21411626</pub-id>
</mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harvey</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>X</given-names></string-name>, et al</person-group>. <article-title>Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT</article-title>. <source>RNA</source>. <year>2018</year>;<volume>24</volume>(<issue>10</issue>):<fpage>1326</fpage>&#x02013;<lpage>1338</lpage>. doi: <pub-id pub-id-type="doi">10.1261/rna.066712.118</pub-id><pub-id pub-id-type="pmid">30042172</pub-id>
</mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Neumann</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Goodall</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Gregory</surname>
<given-names>PA</given-names></string-name></person-group>. <article-title>Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity</article-title>. <source>Semin Cell Dev Biol</source>. <year>2018</year>;<volume>75</volume>:<fpage>50</fpage>&#x02013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.semcdb.2017.08.008</pub-id><pub-id pub-id-type="pmid">28789987</pub-id>
</mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shapiro</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Flytzanis</surname>
<given-names>NC</given-names></string-name>, et al</person-group>. <article-title>An EMT&#x02013;driven alternative splicing program occurs in human breast Cancer and modulates cellular phenotype</article-title>. <source>PLoS Genet</source>. <year>2011</year>;<volume>7</volume>(<issue>8</issue>):<fpage>e1002218</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1002218</pub-id><pub-id pub-id-type="pmid">21876675</pub-id>
</mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Bebee</surname>
<given-names>TW</given-names></string-name>, et al</person-group>. <article-title>Determination of a comprehensive alternative splicing regulatory network and combinatorial regulation by key factors during the epithelial-to-mesenchymal transition</article-title>. <source>Mol Cell Biol</source>. <year>2016</year>;<volume>36</volume>(<issue>11</issue>):<fpage>1704</fpage>&#x02013;<lpage>1719</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MCB.00019-16</pub-id><pub-id pub-id-type="pmid">27044866</pub-id>
</mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Chaffer</surname>
<given-names>CL</given-names></string-name>, et al</person-group>. <article-title>An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer</article-title>. <source>Elife</source>. <year>2018</year>;<volume>7</volume>: doi: <pub-id pub-id-type="doi">10.7554/eLife.37184</pub-id></mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pillman</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Phillips</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Roslan</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA -binding protein Quaking</article-title>. <source>The EMBO Journal</source>. <year>2018</year>;<volume>37</volume>(<issue>13</issue>):<fpage>miR</fpage>&#x02013;<lpage>200/375</lpage>. doi: <pub-id pub-id-type="doi">10.15252/embj.201899016</pub-id></mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Tonissen</surname>
<given-names>K</given-names></string-name>, et al</person-group>. <article-title>The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>(<issue>41</issue>):<fpage>29202</fpage>&#x02013;<lpage>29210</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.274.41.29202</pub-id><pub-id pub-id-type="pmid">10506177</pub-id>
</mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Larocque</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Galarneau</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>HN</given-names></string-name>, et al</person-group>. <article-title>Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation</article-title>. <source>Nat Neurosci</source>. <year>2005</year>;<volume>8</volume>(<issue>1</issue>):<fpage>27</fpage>&#x02013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn1359</pub-id><pub-id pub-id-type="pmid">15568022</pub-id>
</mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Larocque</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pilotte</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Nuclear retention of mbp mRnas in the quaking viable mice</article-title>. <source>Neuron</source>. <year>2002</year>;<volume>36</volume>(<issue>5</issue>):<fpage>815</fpage>&#x02013;<lpage>829</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0896-6273(02)01055-3</pub-id><pub-id pub-id-type="pmid">12467586</pub-id>
</mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Neumann</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Goodall</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Gregory</surname>
<given-names>PA</given-names></string-name></person-group>. <article-title>The Quaking RNA-binding proteins as regulators of cell differentiation</article-title>. <source>Wiley Interdiscip Rev RNA</source>. <year>2022</year>;<volume>13</volume>(<issue>6</issue>):<fpage>e1724</fpage>. doi: <pub-id pub-id-type="doi">10.1002/wrna.1724</pub-id><pub-id pub-id-type="pmid">35298877</pub-id>
</mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sakers</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Llaci</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Loss of Quaking RNA binding protein disrupts the expression of genes associated with astrocyte maturation in mouse brain</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1537</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-21703-5</pub-id><pub-id pub-id-type="pmid">33750804</pub-id>
</mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamagishi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Tsusaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mitsunaga</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title>The star protein QKI-7 recruits PAPD4 to regulate post-transcriptional polyadenylation of target mRnas</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year>;<volume>44</volume>(<issue>6</issue>):<fpage>2475</fpage>&#x02013;<lpage>2490</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkw118</pub-id><pub-id pub-id-type="pmid">26926106</pub-id>
</mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ku</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>QKI binds map1b mrna and enhances map1b expression during oligodendrocyte development</article-title>. <source>Mol Biol Cell</source>. <year>2006</year>;<volume>17</volume>(<issue>10</issue>):<fpage>4179</fpage>&#x02013;<lpage>4186</lpage>. doi: <pub-id pub-id-type="doi">10.1091/mbc.e06-04-0355</pub-id><pub-id pub-id-type="pmid">16855020</pub-id>
</mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mitschka</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mayr</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Context-specific regulation and function of mRNA alternative polyadenylation</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2022</year>;<volume>23</volume>(<issue>12</issue>):<fpage>779</fpage>&#x02013;<lpage>796</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41580-022-00507-5</pub-id><pub-id pub-id-type="pmid">35798852</pub-id>
</mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tian</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Manley</surname>
<given-names>JL</given-names></string-name></person-group>. <article-title>Alternative polyadenylation of mRNA precursors</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2017</year>;<volume>18</volume>(<issue>1</issue>):<fpage>18</fpage>&#x02013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm.2016.116</pub-id><pub-id pub-id-type="pmid">27677860</pub-id>
</mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mayr</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bartel</surname>
<given-names>DP</given-names></string-name></person-group>. <article-title>Widespread shortening of 3&#x02032;UTRs by alternative cleavage and polyadenylation activates oncogenes in Cancer cells</article-title>. <source>Cell</source>. <year>2009</year>;<volume>138</volume>(<issue>4</issue>):<fpage>673</fpage>&#x02013;<lpage>684</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2009.06.016</pub-id><pub-id pub-id-type="pmid">19703394</pub-id>
</mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xia</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Donehower</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Cooper</surname>
<given-names>TA</given-names></string-name>, et al</person-group>. <article-title>Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3&#x02032;-UTR landscape across seven tumour types</article-title>. <source>Nat Commun</source>. <year>2014</year>;<volume>5</volume>(<issue>1</issue>):<fpage>5274</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms6274</pub-id><pub-id pub-id-type="pmid">25409906</pub-id>
</mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lianoglou</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Garg</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>JL</given-names></string-name>, et al</person-group>. <article-title>Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression</article-title>. <source>Genes Dev</source>. <year>2013</year>;<volume>27</volume>(<issue>21</issue>):<fpage>2380</fpage>&#x02013;<lpage>2396</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.229328.113</pub-id><pub-id pub-id-type="pmid">24145798</pub-id>
</mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Yehia</surname>
<given-names>G</given-names></string-name>, et al</person-group>. <article-title>A compendium of conserved cleavage and polyadenylation events in mammalian genes</article-title>. <source>Genome Res</source>. <year>2018</year>;<volume>28</volume>(<issue>10</issue>):<fpage>1427</fpage>&#x02013;<lpage>1441</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gr.237826.118</pub-id><pub-id pub-id-type="pmid">30143597</pub-id>
</mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harrison</surname>
<given-names>PF</given-names></string-name>, <string-name><surname>Powell</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Clancy</surname>
<given-names>JL</given-names></string-name>, et al</person-group>. <article-title>PAT-seq: a method to study the integration of 3&#x02032;-UTR dynamics with gene expression in the eukaryotic transcriptome</article-title>. <source>RNA</source>. <year>2015</year>;<volume>21</volume>(<issue>8</issue>):<fpage>1502</fpage>&#x02013;<lpage>1510</lpage>. doi: <pub-id pub-id-type="doi">10.1261/rna.048355.114</pub-id><pub-id pub-id-type="pmid">26092945</pub-id>
</mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Swaminathan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Harrison</surname>
<given-names>PF</given-names></string-name>, <string-name><surname>Preiss</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>PAT-Seq: a method for simultaneous quantitation of gene expression, poly(A)-site selection and poly(A)-length distribution in yeast transcriptomes</article-title>. <source>Methods Mol Biol</source>. <year>2019</year>;<volume>2049</volume>:<fpage>141</fpage>&#x02013;<lpage>164</lpage>.<pub-id pub-id-type="pmid">31602610</pub-id>
</mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Darbelli</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Choquet</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Richard</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Transcriptome profiling of mouse brains with qkI-deficient oligodendrocytes reveals major alternative splicing defects including self-splicing</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>7554</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-017-06211-1</pub-id><pub-id pub-id-type="pmid">28790308</pub-id>
</mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fagg</surname>
<given-names>WS</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Fair</surname>
<given-names>JH</given-names></string-name>, et al</person-group>. <article-title>Autogenous cross-regulation of Quaking mRNA processing and translation balances quaking functions in splicing and translation</article-title>. <source>Genes Dev</source>. <year>2017</year>;<volume>31</volume>(<issue>18</issue>):<fpage>1894</fpage>&#x02013;<lpage>1909</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.302059.117</pub-id><pub-id pub-id-type="pmid">29021242</pub-id>
</mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hafner</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Katsantoni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>K&#x000f6;ster</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>CLIP and complementary methods</article-title>. <source>Nat Rev Dis Primers</source>. <year>2021</year>;<volume>1</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s43586-021-00018-1</pub-id></mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hafner</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Landthaler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Burger</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP</article-title>. <source>Cell</source>. <year>2010</year>;<volume>141</volume>(<issue>1</issue>):<fpage>129</fpage>&#x02013;<lpage>141</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2010.03.009</pub-id><pub-id pub-id-type="pmid">20371350</pub-id>
</mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van Nostrand</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Pratt</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Shishkin</surname>
<given-names>AA</given-names></string-name>, et al</person-group>. <article-title>Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)</article-title>. <source>Nat Methods</source>. <year>2016</year>;<volume>13</volume>(<issue>6</issue>):<fpage>508</fpage>&#x02013;<lpage>514</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.3810</pub-id><pub-id pub-id-type="pmid">27018577</pub-id>
</mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Galarneau</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Richard</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Target RNA motif and target mRnas of the Quaking STAR protein</article-title>. <source>Nat Struct Mol Biol</source>. <year>2005</year>;<volume>12</volume>(<issue>8</issue>):<fpage>691</fpage>&#x02013;<lpage>698</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nsmb963</pub-id><pub-id pub-id-type="pmid">16041388</pub-id>
</mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herrmann</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Schmidt</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kanitz</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>PolyASite 2.0: a consolidated atlas of polyadenylation sites from 3&#x02019; end sequencing</article-title>. <source>Nucleic Acids Res</source>. <year>2020</year>;<volume>48</volume>:<fpage>D174</fpage>&#x02013;<lpage>D179</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkz918</pub-id><pub-id pub-id-type="pmid">31617559</pub-id>
</mixed-citation></ref><ref id="cit0035"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barretina</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Caponigro</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Stransky</surname>
<given-names>N</given-names></string-name>, et al</person-group>. <article-title>The Cancer cell line Encyclopedia enables predictive modelling of anticancer drug sensitivity</article-title>. <source>Nature</source>. <year>2012</year>;<volume>483</volume>(<issue>7391</issue>):<fpage>603</fpage>&#x02013;<lpage>607</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature11003</pub-id><pub-id pub-id-type="pmid">22460905</pub-id>
</mixed-citation></ref><ref id="cit0036"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dittmar</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>JW</given-names></string-name>, et al</person-group>. <article-title>Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing</article-title>. <source>Mol Cell Biol</source>. <year>2012</year>;<volume>32</volume>(<issue>8</issue>):<fpage>1468</fpage>&#x02013;<lpage>1482</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MCB.06536-11</pub-id><pub-id pub-id-type="pmid">22354987</pub-id>
</mixed-citation></ref><ref id="cit0037"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chhabra</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Higgs</surname>
<given-names>HN</given-names></string-name></person-group>. <article-title>INF2 is a WASP homology 2 motif-containing formin that severs actin filaments and accelerates both polymerization and depolymerization</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>36</issue>):<fpage>26754</fpage>&#x02013;<lpage>26767</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M604666200</pub-id><pub-id pub-id-type="pmid">16818491</pub-id>
</mixed-citation></ref><ref id="cit0038"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schell</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rogg</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Suhm</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2017</year>;<volume>114</volume>(<issue>23</issue>):<fpage>E4621</fpage>&#x02013;<lpage>E4630</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1617004114</pub-id><pub-id pub-id-type="pmid">28536193</pub-id>
</mixed-citation></ref><ref id="cit0039"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doukhanine</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gavino</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Haines</surname>
<given-names>JD</given-names></string-name>, et al</person-group>. <article-title>The QKI-6 RNA binding protein regulates actin-interacting protein-1 mRNA stability during oligodendrocyte differentiation</article-title>. <source>Mol Biol Cell</source>. <year>2010</year>;<volume>21</volume>(<issue>17</issue>):<fpage>3029</fpage>&#x02013;<lpage>3040</lpage>. doi: <pub-id pub-id-type="doi">10.1091/mbc.e10-04-0305</pub-id><pub-id pub-id-type="pmid">20631256</pub-id>
</mixed-citation></ref><ref id="cit0040"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thangaraj</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Furber</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Gan</surname>
<given-names>JK</given-names></string-name>, et al</person-group>. <article-title>RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation</article-title>. <source>J Biol Chem</source>. <year>2017</year>;<volume>292</volume>(<issue>13</issue>):<fpage>5166</fpage>&#x02013;<lpage>5182</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M117.775544</pub-id><pub-id pub-id-type="pmid">28188285</pub-id>
</mixed-citation></ref><ref id="cit0041"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brumbaugh</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Di Stefano</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, et al</person-group>. <article-title>Nudt21 controls cell fate by connecting alternative polyadenylation to chromatin signaling</article-title>. <source>Cell</source>. <year>2018</year>;<volume>172</volume>(<issue>1&#x02013;2</issue>):<fpage>106</fpage>&#x02013;<lpage>120 e121</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2017.11.023</pub-id><pub-id pub-id-type="pmid">29249356</pub-id>
</mixed-citation></ref><ref id="cit0042"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lau</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Irier</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Gu</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Distinct 3&#x02032;UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF)</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2010</year>;<volume>107</volume>(<issue>36</issue>):<fpage>15945</fpage>&#x02013;<lpage>15950</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1002929107</pub-id><pub-id pub-id-type="pmid">20733072</pub-id>
</mixed-citation></ref><ref id="cit0043"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aiello</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Maddipati</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Norgard</surname>
<given-names>RJ</given-names></string-name>, et al</person-group>. <article-title>EMT subtype influences epithelial plasticity and mode of cell migration</article-title>. <source>Developmental Cell</source>. <year>2018</year>;<volume>45</volume>(<issue>6</issue>):<fpage>681</fpage>&#x02013;<lpage>695 e684</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.devcel.2018.05.027</pub-id><pub-id pub-id-type="pmid">29920274</pub-id>
</mixed-citation></ref><ref id="cit0044"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berkovits</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Mayr</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>Alternative 3&#x02032; UTRs act as scaffolds to regulate membrane protein localization</article-title>. <source>Nature</source>. <year>2015</year>;<volume>522</volume>(<issue>7556</issue>):<fpage>363</fpage>&#x02013;<lpage>367</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature14321</pub-id><pub-id pub-id-type="pmid">25896326</pub-id>
</mixed-citation></ref><ref id="cit0045"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muller-McNicoll</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rossbach</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Hui</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Auto-regulatory feedback by RNA-binding proteins</article-title>. <source>J Mol Cell Biol</source>. <year>2019</year>;<volume>11</volume>(<issue>10</issue>):<fpage>930</fpage>&#x02013;<lpage>939</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jmcb/mjz043</pub-id><pub-id pub-id-type="pmid">31152582</pub-id>
</mixed-citation></ref><ref id="cit0046"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mani</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>MJ</given-names></string-name>, et al</person-group>. <article-title>The epithelial-mesenchymal transition generates cells with properties of stem cells</article-title>. <source>Cell</source>. <year>2008</year>;<volume>133</volume>(<issue>4</issue>):<fpage>704</fpage>&#x02013;<lpage>715</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2008.03.027</pub-id><pub-id pub-id-type="pmid">18485877</pub-id>
</mixed-citation></ref><ref id="cit0047"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jensen</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Darnell</surname>
<given-names>RB</given-names></string-name></person-group>. <article-title>CLIP: crosslinking and immunoprecipitation of in vivo RNA targets of RNA-binding proteins</article-title>. <source>Methods Mol Biol</source>. <year>2008</year>;<volume>488</volume>:<fpage>85</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">18982285</pub-id>
</mixed-citation></ref><ref id="cit0048"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sutandy</surname>
<given-names>FX</given-names></string-name>, <string-name><surname>Hildebrandt</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Konig</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Profiling the binding sites of RNA-Binding proteins with nucleotide resolution using iCLIP</article-title>. <source>Methods Mol Biol</source>. <year>2016</year>;<volume>1358</volume>:<fpage>175</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">26463384</pub-id>
</mixed-citation></ref><ref id="cit0049"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Turner</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Henneken</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Liem-Weits</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Requirement for cleavage factor II m in the control of alternative polyadenylation in breast cancer cells</article-title>. <source>RNA</source>. <year>2020</year>;<volume>26</volume>(<issue>8</issue>):<fpage>969</fpage>&#x02013;<lpage>981</lpage>. doi: <pub-id pub-id-type="doi">10.1261/rna.075226.120</pub-id><pub-id pub-id-type="pmid">32295865</pub-id>
</mixed-citation></ref><ref id="cit0050"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Meyer</surname>
<given-names>CA</given-names></string-name>, et al</person-group>. <article-title>Model-based analysis of ChIP-Seq (MACS)</article-title>. <source>Genome Biol</source>. <year>2008</year>;<volume>9</volume>(<issue>9</issue>):<fpage>R137</fpage>. doi: <pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id><pub-id pub-id-type="pmid">18798982</pub-id>
</mixed-citation></ref><ref id="cit0051"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heinz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Benner</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Spann</surname>
<given-names>N</given-names></string-name>, et al</person-group>. <article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title>. <source>Mol Cell</source>. <year>2010</year>;<volume>38</volume>(<issue>4</issue>):<fpage>576</fpage>&#x02013;<lpage>589</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id>
</mixed-citation></ref><ref id="cit0052"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thorvaldsdottir</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Robinson</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Mesirov</surname>
<given-names>JP</given-names></string-name></person-group>. <article-title>Integrative Genomics viewer (IGV): high-performance genomics data visualization and exploration</article-title>. <source>Brief Bioinform</source>. <year>2013</year>;<volume>14</volume>(<issue>2</issue>):<fpage>178</fpage>&#x02013;<lpage>192</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bib/bbs017</pub-id><pub-id pub-id-type="pmid">22517427</pub-id>
</mixed-citation></ref><ref id="cit0053"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kent</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Sugnet</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Furey</surname>
<given-names>TS</given-names></string-name>, et al</person-group>. <article-title>The human genome browser at UCSC</article-title>. <source>Genome Res</source>. <year>2002</year>;<volume>12</volume>(<issue>6</issue>):<fpage>996</fpage>&#x02013;<lpage>1006</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gr.229102</pub-id><pub-id pub-id-type="pmid">12045153</pub-id>
</mixed-citation></ref><ref id="cit0054"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jaehnig</surname>
<given-names>EJ</given-names></string-name>, et al</person-group>. <article-title>Webgestalt 2019: gene set analysis toolkit with revamped UIs and APIs</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>;<volume>47</volume>(<issue>W1</issue>):<fpage>W199</fpage>&#x02013;<lpage>W205</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkz401</pub-id><pub-id pub-id-type="pmid">31114916</pub-id>
</mixed-citation></ref></ref-list></back></article>
